Advent Pharma Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	48.03	66.87	83.99	98.64	97.53	113.59
Depreciation & Amortization	63.05	63.05	66.51	59.18	42.27	38.75
Loss (Gain) From Sale of Assets	-	-	29.61	0.02	-	0.39
Other Operating Activities	-24.72	28.53	29.68	38.47	38.36	24.42
Change in Accounts Receivable	-45.71	-45.71	-16.32	-10.32	-2.15	4.21
Change in Inventory	1.07	1.07	12.51	0.78	-5.12	-7.53
Change in Accounts Payable	0.44	0.44	-10.96	10.83	1.08	-1.31
Change in Other Net Operating Assets	0.49	0.49	-19.89	7.7	7.6	7.86
Operating Cash Flow	42.65	114.74	175.13	205.3	179.57	180.38
Operating Cash Flow Growth	-55.89%	-34.48%	-14.69%	14.33%	-0.45%	6.05%
Capital Expenditures	-42.4	-94.18	-162.06	-202.73	-191.13	-184.06
Sale of Property, Plant & Equipment	-	-	2.7	0.68	-	0.23
Investment in Securities	-	-	-	-	40	-
Investing Cash Flow	-42.4	-94.18	-159.36	-202.06	-151.13	-183.83
Short-Term Debt Issued	-	-	5.01	11.72	6.44	13.47
Total Debt Issued	2.6	-	5.01	11.72	6.44	13.47
Short-Term Debt Repaid	-	-1.33	-	-	-	-
Long-Term Debt Repaid	-	-0.64	-0.59	-4.04	-4.2	-2.59
Total Debt Repaid	-1.22	-1.97	-0.59	-4.04	-4.2	-2.59
Net Debt Issued (Repaid)	1.38	-1.97	4.42	7.68	2.25	10.88
Common Dividends Paid	-2.06	-14.75	-8.2	-8.81	-22.22	-8.08
Other Financing Activities	-2.28	-6.04	-9.1	-5.35	-6.84	-3.01
Financing Cash Flow	-2.96	-22.76	-12.88	-6.48	-26.82	-0.21
Miscellaneous Cash Flow Adjustments	-0	-0	0	-	-	-
Net Cash Flow	-2.71	-2.2	2.89	-3.24	1.63	-3.65
Free Cash Flow	0.25	20.56	13.08	2.56	-11.56	-3.67
Free Cash Flow Growth	-98.86%	57.25%	409.89%	-	-	-
Free Cash Flow Margin	0.06%	4.11%	2.29%	0.46%	-2.18%	-0.73%
Free Cash Flow Per Share	0.00	0.22	0.14	0.03	-0.12	-0.04
Cash Interest Paid	6.04	6.04	9.1	5.35	6.83	3.01
Cash Income Tax Paid	0.24	0.24	2.86	3.08	2.36	3.9
Levered Free Cash Flow	-18.32	-20.56	-36.41	-44.03	-68.27	-56.36
Unlevered Free Cash Flow	-12.4	-14.84	-31.35	-39.89	-65.7	-53.3
Change in Working Capital	-43.71	-43.71	-34.66	8.99	1.41	3.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.